ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Launches Nasodine in Singapore
|
|
Torpy
|
8 |
2.2K |
8 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
8
|
2.2K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
Short Term trading, analysis and TLX noise - No investors keep out
|
|
Torpy
|
545 |
188K |
0 |
07/06/24 |
07/06/24 |
ASX - By Stock
|
545
|
188K
|
0
|
|
ASX - By Stock
|
AD8 |
Re:
AD8 TA
|
|
Torpy
|
137 |
63K |
4 |
29/05/24 |
29/05/24 |
ASX - By Stock
|
137
|
63K
|
4
|
|
ASX - By Stock
|
AD8 |
Re:
AD8 TA
|
|
Torpy
|
137 |
63K |
4 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
137
|
63K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Capital Raise
|
|
Torpy
|
30 |
11K |
4 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
30
|
11K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Capital Raise
|
|
Torpy
|
30 |
11K |
11 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
30
|
11K
|
11
|
|
ASX - By Stock
|
FRE |
Re:
DR Peter M - sales in the first half of the year ?
|
|
Torpy
|
1 |
608 |
0 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
1
|
608
|
0
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Torpy
|
4.1K |
1.9M |
5 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
4.1K
|
1.9M
|
5
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Torpy
|
4.1K |
1.9M |
4 |
13/04/24 |
13/04/24 |
ASX - By Stock
|
4.1K
|
1.9M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR to present at NWR Healthcare Conference
|
|
Torpy
|
54 |
17K |
21 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
54
|
17K
|
21
|
|
ASX - By Stock
|
UBI |
Re:
Ann: FDA Approval for Xprecia Prime
|
|
Torpy
|
113 |
28K |
2 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
113
|
28K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
where are we at at the moment ?
|
|
Torpy
|
40 |
14K |
4 |
10/03/24 |
10/03/24 |
ASX - By Stock
|
40
|
14K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Half Yearly Report and Accounts
|
|
Torpy
|
37 |
13K |
11 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
37
|
13K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
Torpy
|
327 |
106K |
10 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
327
|
106K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
Torpy
|
327 |
106K |
28 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
327
|
106K
|
28
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Receives $7.36m R&D Tax Incentive Refund
|
|
Torpy
|
52 |
17K |
9 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
52
|
17K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
PAR. SP
|
|
Torpy
|
974 |
324K |
1 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
974
|
324K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Torpy
|
670 |
256K |
3 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
670
|
256K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Torpy
|
670 |
256K |
11 |
17/12/23 |
17/12/23 |
ASX - By Stock
|
670
|
256K
|
11
|
|
ASX - By Stock
|
BGT |
Re:
Ann: BGT 2023AGM - Chairman's Address
|
|
Torpy
|
11 |
2.6K |
4 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
11
|
2.6K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Pre-AGM Update
|
|
Torpy
|
42 |
14K |
5 |
20/11/23 |
20/11/23 |
ASX - By Stock
|
42
|
14K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
AGM 2024 - QUESTIONS
|
|
Torpy
|
151 |
47K |
9 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
151
|
47K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Torpy
|
670 |
256K |
18 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
670
|
256K
|
18
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Torpy
|
4.2K |
3.8M |
14 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
4.2K
|
3.8M
|
14
|
|
ASX - By Stock
|
PAR |
Re:
PAR Capital Position and 2024 Raising Requirements
|
|
Torpy
|
120 |
41K |
3 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
120
|
41K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
Torpy
|
670 |
256K |
13 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
670
|
256K
|
13
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Successful Placement and Fully Underwritten ANREO
|
|
Torpy
|
191 |
56K |
3 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
191
|
56K
|
3
|
|
ASX - By Stock
|
XRO |
Re:
Ann: H1 FY24 Market Release
|
|
Torpy
|
30 |
19K |
0 |
09/11/23 |
09/11/23 |
ASX - By Stock
|
30
|
19K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Torpy
|
4.2K |
3.8M |
10 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
4.2K
|
3.8M
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial
|
|
Torpy
|
218 |
74K |
7 |
21/10/23 |
21/10/23 |
ASX - By Stock
|
218
|
74K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial
|
|
Torpy
|
218 |
74K |
43 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
218
|
74K
|
43
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial
|
|
Torpy
|
218 |
74K |
12 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
218
|
74K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
The Granular Link.
|
|
Torpy
|
5 |
1.8K |
8 |
16/10/23 |
16/10/23 |
ASX - By Stock
|
5
|
1.8K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Torpy
|
4.2K |
3.8M |
2 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
4.2K
|
3.8M
|
2
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Phase 3 Common Cold Trial Results
|
|
Torpy
|
90 |
35K |
4 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
90
|
35K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Torpy
|
4.1K |
1.9M |
12 |
03/09/23 |
03/09/23 |
ASX - By Stock
|
4.1K
|
1.9M
|
12
|
|
ASX - By Stock
|
BGT |
Re:
Ann: BGT selected for USA CDC Funded Program
|
|
Torpy
|
27 |
4.4K |
15 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
27
|
4.4K
|
15
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
Torpy
|
4.1K |
1.9M |
28 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
4.1K
|
1.9M
|
28
|
|
ASX - By Stock
|
PAR |
Re:
Kumagai, one of the Fantastic Four and some Mozz Firsts...
|
|
Torpy
|
51 |
16K |
7 |
02/06/23 |
02/06/23 |
ASX - By Stock
|
51
|
16K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Torpy
|
4.2K |
3.8M |
14 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
4.2K
|
3.8M
|
14
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study
|
|
Torpy
|
386 |
164K |
18 |
23/04/23 |
23/04/23 |
ASX - By Stock
|
386
|
164K
|
18
|
|
ASX - By Stock
|
PAR |
Re:
Funding options
|
|
Torpy
|
20 |
6.7K |
8 |
19/04/23 |
19/04/23 |
ASX - By Stock
|
20
|
6.7K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
The P Value Primer
|
|
Torpy
|
13 |
6.1K |
7 |
11/04/23 |
11/04/23 |
ASX - By Stock
|
13
|
6.1K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
The P Value Primer
|
|
Torpy
|
13 |
6.1K |
16 |
11/04/23 |
11/04/23 |
ASX - By Stock
|
13
|
6.1K
|
16
|
|
ASX - By Stock
|
IXC |
Re:
DCF Valuation Model for Invex Therapeutics
|
|
Torpy
|
241 |
48K |
1 |
05/04/23 |
05/04/23 |
ASX - By Stock
|
241
|
48K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Torpy
|
139 |
63K |
6 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
139
|
63K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
Torpy
|
139 |
63K |
23 |
02/04/23 |
02/04/23 |
ASX - By Stock
|
139
|
63K
|
23
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Poster Presentation to OARSI World Congress 2023
|
|
Torpy
|
11 |
4.6K |
22 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
11
|
4.6K
|
22
|
|
ASX - By Stock
|
PAR |
Re:
MOZZ OARSI 2023 - NOTES
|
|
Torpy
|
79 |
33K |
9 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
79
|
33K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
MOZZ OARSI 2023 - NOTES
|
|
Torpy
|
79 |
33K |
6 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
79
|
33K
|
6
|
|